Calimpong, Elenita G.
HRN: 24-03-28 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/03/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
11/03/2023
11/17/2023
IV
500mg
BID
H Pylori Infection
Checking Final Appropriateness
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes